Tracer library / [99mTc]TcO-depreotide

[99mTc]TcO-depreotide

Also written as NeoTect; [99mTc]TcO-depreotide
Radionuclide
Tc-99m
Modality
—
Production route
—
Stage
Approved
Syntheses indexed
0
Lung cancer

What it is

Compound class
Somatostatin receptor-binding peptide (99mTc-labeled tripeptide chelate, oxotechnetium peptide complex)
Target / mechanism
Somatostatin receptor PMID 17315859
Clinical application
Imaging of lung cancer PMID 17691766
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Need this precursor?We can point you to suppliers for [99mTc]TcO-depreotide, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 17315859, 17691766. Stage set/updated at stage 39 from PMID 17691766: 'the approved radiopharmaceutical [99mTcO]depreotide ([99mTcO]P829, NeoTect) that is used to image lung cancer'.